Who we are:
We're building a world-class team, founded by world leaders in gene editing, with rapid consolidation of base editing technology. Beam's co-founders helped put CRISPR gene editing on the map, and with Beam they're coming together again to pursue therapies for serious diseases using groundbreaking base editing technology.
What we do:
Over half of the genetic errors associated with disease result from a single-letter change in the billions of bases that form the genome. In other cases, certain natural genetic variations in DNA are known to protect against disease. By changing a single letter – to eliminate errors or write in protective changes – in enough cells, base editing may help us prevent, modify, and even cure a wide range of diseases affecting patients' lives.
Beam's Founders celebrating the launch of Beam!
Receiving 2019 Nevy Award - Beam receives top honors as the recipient of Revolutionary Therapeutic or Platform Startup!
Beam Team Halloween 2018!
Beam's 100th Employee Celebration!